Qube Research & Technologies (QRT)
BIVI icon

Qube Research & Technologies (QRT)’s BioVie BIVI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77
Closed -$9.69K – 4471
2023
Q4 		$9.69K Buy
+77
New +$23.1K ﹤0.01% 3613

Other funds holding BIVI

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIVI Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of BioVie (BIVI) in Q1 2024, closing a stake of 77 shares — an estimated $9.69K sold.

Qube Research & Technologies (QRT) first reported a position in BIVI in Q4 2023 and held it in 1 quarter. The position peaked at $9.69K in Q4 2023. 49 funds tracked by Wall St. Rank hold BIVI as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining BioVie position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 77 BioVie shares in Q1 2024, an estimated $9.69K.
  • Qube Research & Technologies (QRT) first reported a position in BioVie in Q4 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s BioVie position peaked at $9.69K in Q4 2023.
  • 49 funds tracked by Wall St. Rank held BioVie as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.